The Burdette lab is interested in women's health. Specifically, we focus on the idea that high grade serous ovarian cancers arise in the fallopian tube and metastasize to the ovary. We are inspired by nature as a source of compounds that function as either progesterone-like molecules or as leads for new cancer therapies to use in ovarian cancer. Finally, we value collaboration and integrate microfluidics, tissue engineering, and imaging into our research program. 

Breaking News

Jose's paper on androgen action in the fallopian tube is accepted to Cancers.

Vedant's review article was accepted to Endocrinology, this is his first first-author paper in the lab.

Ally matches at Brigham and Women's Hospital and Laura at Cincinnati Children's Hospital for their residencies.  Awesome!

Tova receives a notice of award for an NIC F30 Award. Thank you Sanchez lab and Kimberly Richardson!


Angela's paper regarding PAX2/PTEN and stem cells accepted to Cell Death and Differentiation.

  • @JBurdetteLab